Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship - PA: CIHR/Rx&D Collaborative Research Program

University of Alberta

$45,000.00

Determining the burden of Inflammatory Bowel Disease: a collaborative, international analysis of data gathered over forty years.

FY 2009-10

Summary
Inflammatory Bowel Disease (IBD) affects one in 200 people in Canada, and is on the rise. Crohn's disease and ulcerative colitis can be severe enough to result in long hospital stays, multiple surgeries, days lost from work due to illness, and potential complications such as permanent disabiltiy, or death. We wish to identify the costs of these illnesses, based on severity. Newer treatments are available to treat these illnesses and are not inexpensive. In addition, the way in which we determine the severity of disease, and its response to these treatments is not clear. While some specialists suggest assess response to treatments based on relief of symptoms, others suggest that we should look for healing of the bowel on colonoscopy. Increasing the use of colonoscopy, along with the use of the newer and more expensive therapies needs to be justified as being a reasonable and cost-saving benefit to IBD patients. Our project, a collaborative effort between Oxford University, the University of Alberta, the University Melbourne (Australia) and potentially the University of Manitoba, will aim to answer the question, 'What impact does inflammatory bowel disease have on the individual and on society'? We will rely on data gathered over forty years, from the databases already in existence at these centres. The international and collaborative nature of our study will only enhance our findings and give them more credibility.
Program
Fellowship - PA: CIHR/Rx&D Collaborative Research Program
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
194064
Name
Siffledeen Jesse S
Region
Alberta
Country
Canada; United Kingdom
Orgtype
Research Institution; Institution Paid
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Health Research Training B - HP
Projecttitle
Determining the burden of Inflammatory Bowel Disease: a collaborative, international analysis of data gathered over forty years.
Programtype2
Fellowship Programs
Orgnameinp2
University of Alberta
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
Fellowship - PA: CIHR/Rx&D Collaborative Research Program
Keyworddelim
Collaborative; Crohn'S Disease; Inflammatory Bowel Disease; International Study; Population Study; Ulcerative Colitis
Abstract
Inflammatory Bowel Disease (IBD) affects one in 200 people in Canada, and is on the rise. Crohn's disease and ulcerative colitis can be severe enough to result in long hospital stays, multiple surgeries, days lost from work due to illness, and potential complications such as permanent disabiltiy, or death. We wish to identify the costs of these illnesses, based on severity. Newer treatments are available to treat these illnesses and are not inexpensive. In addition, the way in which we determine the severity of disease, and its response to these treatments is not clear. While some specialists suggest assess response to treatments based on relief of symptoms, others suggest that we should look for healing of the bowel on colonoscopy. Increasing the use of colonoscopy, along with the use of the newer and more expensive therapies needs to be justified as being a reasonable and cost-saving benefit to IBD patients. Our project, a collaborative effort between Oxford University, the University of Alberta, the University Melbourne (Australia) and potentially the University of Manitoba, will aim to answer the question, 'What impact does inflammatory bowel disease have on the individual and on society'? We will rely on data gathered over forty years, from the databases already in existence at these centres. The international and collaborative nature of our study will only enhance our findings and give them more credibility.
Competitiondate
200910
Approvedterm2
1 yr 0 mth
Pinamesdelim
Siffledeen, Jesse S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $45,000~ $0~